The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects: A Pilot Study

Trial Profile

The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects: A Pilot Study

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2014

At a glance

  • Drugs Orlistat (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 May 2013 Planned end date changed from 1 Aug 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
    • 24 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 06 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top